- 期刊
Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies
延伸閱讀
- Amm, J. E., Freeman, A., Patel, N., & Ching, J. B. A. (2013). Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms. Prostate Cancer, 2013(), 24-33. https://doi.org/10.1155/2013/210686
- Goyal, J., & Antonarakis, E. S. (2013). Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate Cancer. Clinical Medicine Insights: Urology, (2013), 1-14. https://doi.org/10.4137/CMU.S8337
- Rahim, F., Hajizamani, S., Mortaz, E., Ahmadzadeh, A., Shahjahani, M., Shahrabi, S., & Saki, N. (2014). Molecular Regulation of Bone Marrow Metastasis in Prostate and Breast Cancer. Bone Marrow Research, (2014), c1-12. https://doi.org/10.1155/2014/405920
- Cheng, W. L., Wang, C. S., Tsai, M. M., & Lin, K. H. (2012). Biomarkers and Oncogenic Pathways in Gastric Cancer. Adaptive Medicine, 4(3), 125-131. https://doi.org/10.4247/AM.2012.ABC028
- Juloori, A., Shah, C., Stephans, K., Vassil, A., & Tendulkar, R. (2016). Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing Controversies. Prostate Cancer, 2016(), 9-20. https://doi.org/10.1155/2016/2420786